187 related articles for article (PubMed ID: 29707828)
1. Enhanced immunity in intradermal vaccination by novel hollow microneedles.
Ogai N; Nonaka I; Toda Y; Ono T; Minegishi S; Inou A; Hachiya M; Fukamizu H
Skin Res Technol; 2018 Nov; 24(4):630-635. PubMed ID: 29707828
[TBL] [Abstract][Full Text] [Related]
2. Microneedle-based vaccines.
Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
[TBL] [Abstract][Full Text] [Related]
3. Hollow microneedle-mediated intradermal delivery of model vaccine antigen-loaded PLGA nanoparticles elicits protective T cell-mediated immunity to an intracellular bacterium.
de Groot AM; Du G; Mönkäre J; Platteel ACM; Broere F; Bouwstra JA; Sijts AJAM
J Control Release; 2017 Nov; 266():27-35. PubMed ID: 28917531
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
[TBL] [Abstract][Full Text] [Related]
5. Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats.
van der Maaden K; Trietsch SJ; Kraan H; Varypataki EM; Romeijn S; Zwier R; van der Linden HJ; Kersten G; Hankemeier T; Jiskoot W; Bouwstra J
Pharm Res; 2014 Jul; 31(7):1846-54. PubMed ID: 24469907
[TBL] [Abstract][Full Text] [Related]
6. Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles.
Du G; Hathout RM; Nasr M; Nejadnik MR; Tu J; Koning RI; Koster AJ; Slütter B; Kros A; Jiskoot W; Bouwstra JA; Mönkäre J
J Control Release; 2017 Nov; 266():109-118. PubMed ID: 28943194
[TBL] [Abstract][Full Text] [Related]
7. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.
Soonawala D; Verdijk P; Wijmenga-Monsuur AJ; Boog CJ; Koedam P; Visser LG; Rots NY
Vaccine; 2013 Aug; 31(36):3688-94. PubMed ID: 23770332
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment.
Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA
Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025
[TBL] [Abstract][Full Text] [Related]
9. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J
J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036
[TBL] [Abstract][Full Text] [Related]
10. Delivery systems for intradermal vaccination.
Kim YC; Jarrahian C; Zehrung D; Mitragotri S; Prausnitz MR
Curr Top Microbiol Immunol; 2012; 351():77-112. PubMed ID: 21472533
[TBL] [Abstract][Full Text] [Related]
11. Efficient antigen delivery to the draining lymph nodes is a key component in the immunogenic pathway of the intradermal vaccine.
Tozuka M; Oka T; Jounai N; Egawa G; Ishii KJ; Kabashima K; Takeshita F
J Dermatol Sci; 2016 Apr; 82(1):38-45. PubMed ID: 26674124
[TBL] [Abstract][Full Text] [Related]
12. BCG vaccine powder-laden and dissolvable microneedle arrays for lesion-free vaccination.
Chen F; Yan Q; Yu Y; Wu MX
J Control Release; 2017 Jun; 255():36-44. PubMed ID: 28390901
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: are all delivery methods the same?
Levin Y; Kochba E; Kenney R
Vaccine; 2014 Jul; 32(34):4249-52. PubMed ID: 24930715
[TBL] [Abstract][Full Text] [Related]
14. Determination of Depth-Dependent Intradermal Immunogenicity of Adjuvanted Inactivated Polio Vaccine Delivered by Microinjections via Hollow Microneedles.
Schipper P; van der Maaden K; Romeijn S; Oomens C; Kersten G; Jiskoot W; Bouwstra J
Pharm Res; 2016 Sep; 33(9):2269-79. PubMed ID: 27317570
[TBL] [Abstract][Full Text] [Related]
15. Hollow microneedles for intradermal injection fabricated by sacrificial micromolding and selective electrodeposition.
Norman JJ; Choi SO; Tong NT; Aiyar AR; Patel SR; Prausnitz MR; Allen MG
Biomed Microdevices; 2013 Apr; 15(2):203-10. PubMed ID: 23053452
[TBL] [Abstract][Full Text] [Related]
16. Enhancing immunogenicity of antigens through sustained intradermal delivery using chitosan microneedles with a patch-dissolvable design.
Chen MC; Lai KY; Ling MH; Lin CW
Acta Biomater; 2018 Jan; 65():66-75. PubMed ID: 29109028
[TBL] [Abstract][Full Text] [Related]
17. Diphtheria toxoid and N-trimethyl chitosan layer-by-layer coated pH-sensitive microneedles induce potent immune responses upon dermal vaccination in mice.
Schipper P; van der Maaden K; Groeneveld V; Ruigrok M; Romeijn S; Uleman S; Oomens C; Kersten G; Jiskoot W; Bouwstra J
J Control Release; 2017 Sep; 262():28-36. PubMed ID: 28710002
[TBL] [Abstract][Full Text] [Related]
18. Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations.
Bal SM; Ding Z; Kersten GF; Jiskoot W; Bouwstra JA
Pharm Res; 2010 Sep; 27(9):1837-47. PubMed ID: 20559701
[TBL] [Abstract][Full Text] [Related]
19. Intradermal inactivated poliovirus vaccine: a preclinical dose-finding study.
Kouiavskaia D; Mirochnitchenko O; Dragunsky E; Kochba E; Levin Y; Troy S; Chumakov K
J Infect Dis; 2015 May; 211(9):1447-50. PubMed ID: 25391313
[TBL] [Abstract][Full Text] [Related]
20. Intradermal vaccination with un-adjuvanted sub-unit vaccines triggers skin innate immunity and confers protective respiratory immunity in domestic swine.
Le Luduec JB; Debeer S; Piras F; Andréoni C; Boudet F; Laurent P; Kaiserlian D; Dubois B
Vaccine; 2016 Feb; 34(7):914-22. PubMed ID: 26768129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
